Studies from our group and others suggest that enhanced tyrosine kinase signaling, re-expression of homeobox (HOX) developmental proteins along with activation of steroid receptor co-activator-1 (SRC-1) proteins cooperate to regulate breast cancer tumor adaptability [3–5]. Here, SRC is linked to breast carcinoma.